UPA PT-141 (Lovers Peptide) 10mg

UPA PT-141 10mg, commonly known as the Lovers Peptide, is a self-mix peptide product containing Bremelanotide (PT-141), a synthetic peptide that acts on melanocortin receptors involved in sexual desire and arousal.

Each package contains a stated 10mg PT-141 vial, accompanied by 2ml of bacteriostatic water.

PT-141 has been investigated for its effects on sexual desire and reproductive behaviour. Unlike medications that primarily influence blood flow, PT-141 acts on central nervous system pathways associated with sexual motivation.

What UPA PT-141 Is Used For

PT-141 is primarily associated with sexual desire and melanocortin receptor activity.

• Female Sexual Desire: Bremelanotide is approved in certain countries for acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women.
• Sexual Arousal Research: Investigated for its influence on neurological pathways involved in sexual arousal.
• Male Sexual Function: Studied experimentally for possible effects on sexual responses and erectile function.
• Libido Regulation: Influences central nervous system pathways associated with sexual motivation.
• Melanocortin Research: Examined for its interactions with receptors involved in sexual behaviour and other physiological functions.
• Non-Hormonal Mechanism: Does not directly increase testosterone or oestrogen production.

How UPA PT-141 Works

PT-141 acts as a melanocortin receptor agonist, influencing neurological pathways associated with sexual desire.

• Melanocortin Receptor Activation: Activates melanocortin receptors involved in sexual behaviour and other physiological responses.
• Central Nervous System Activity: Influences brain pathways associated with sexual motivation and arousal.
• MC4R Signalling: Interacts with melanocortin-4 receptors, which are involved in several neurological processes.
• Sexual Response Regulation: May influence the body's neurological response to sexual stimulation.
• Non-Vascular Mechanism: Unlike sildenafil or tadalafil, PT-141 does not primarily work by increasing blood flow through PDE5 inhibition.
• Non-Androgenic Activity: Does not act as an anabolic steroid or directly stimulate androgen receptors.

Possible Side Effects

Bremelanotide may cause adverse effects involving the gastrointestinal, cardiovascular and nervous systems.

Common or Recognised Side Effects:

• Nausea, sometimes severe.
• Facial flushing or temporary warmth.
• Headaches.
• Vomiting.
• Injection-site redness, swelling or irritation.
• Temporary increases in blood pressure.
• Temporary decreases in heart rate.
• Dizziness or general discomfort.
• Darkening of the skin or gums.